Clinical Trial

AnticoaguLation ONE Year After Ablation of Atrial Fibrillation in Patients With Atrial Fibrillation (ALONE AF Study)

Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated February 6, 2023 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.
Summary
There has no evidence for the anticoagulation in patients who had undergone catheter ablation of atrial fibrillation, and has maintained sinus rhythm for more than 1 year. However, anticoagulation can increase the risk of bleeding, the study evaluating the role of oral anticoagulation is needed in this patients. This study will compare the efficacy and safety of non-vitamin K anticoagulants (apixaban) and no oral anticoagulation in patient with sinus rhythm one year after catheter ablation of AF.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2020-06-12; most recent amendment 2023-02-01.
Status change: Not Yet Recruiting → Recruiting 2020-08-11
Trial Details
NCT Number NCT04432220
Lead Sponsor Yonsei University
Conditions Atrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial Fibrillation
Enrollment 840 participants
Start Date 2020-07-28
Primary Completion 2026-07 (estimated)
Study Completion 2028-10 (estimated)
Updated on ClinicalTrials.gov 2023-02-06